Boivin G, Edelman C K, Pedneault L, Talarico C L, Biron K K, Balfour H H
Dept. of Laboratory Medicine and Pathology, Minneapolis, MN 55455-0392.
J Infect Dis. 1994 Jul;170(1):68-75. doi: 10.1093/infdis/170.1.68.
Phenotypic and genotypic analyses were done on 17 varicella-zoster virus (VZV) isolates recovered from 10 persons with AIDS (mean CD4 cell count, 16.4/mm3) who had chronic VZV lesions. Eleven acyclovir-resistant isolates were recovered from 10 patients after a mean of 20.1 weeks of therapy. Six susceptible isolates were recovered before acyclovir treatment (n = 1), early during therapy (n = 4; mean time, 4.2 weeks), or after discontinuation of acyclovir (n = 1). Acyclovir-resistant VZV isolates were deficient in thymidine kinase (TK) or induced a TK with altered substrate specificity; all isolates were susceptible to foscarnet. Ten of 11 acyclovir-resistant mutants contained tk gene mutations, including single nucleotide substitutions in highly conserved binding sites (n = 2) as well as nucleotide deletions (n = 4) and insertions (n = 4). These findings suggest that multiple, nonuniform mutations within the tk gene are associated with acyclovir-resistant VZV phenotypes.
对从10名患有慢性水痘带状疱疹病毒(VZV)皮损的艾滋病患者(平均CD4细胞计数为16.4/mm³)中分离出的17株VZV进行了表型和基因型分析。在平均20.1周的治疗后,从10名患者中分离出11株耐阿昔洛韦的毒株。在阿昔洛韦治疗前(n = 1)、治疗早期(n = 4;平均时间为4.2周)或阿昔洛韦停药后(n = 1)分离出6株敏感毒株。耐阿昔洛韦的VZV毒株胸苷激酶(TK)缺乏或诱导产生底物特异性改变的TK;所有毒株对膦甲酸钠敏感。11株耐阿昔洛韦突变体中有10株含有tk基因突变,包括高度保守结合位点的单核苷酸替换(n = 2)以及核苷酸缺失(n = 4)和插入(n = 4)。这些发现表明,tk基因内的多个非一致性突变与耐阿昔洛韦的VZV表型相关。